105 related articles for article (PubMed ID: 13049572)
1. The concentration of PAS in the blood during medication with PAS or PAS-salts.
NILSSON H
Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
[No Abstract] [Full Text] [Related]
2. [PAS concentration in blood in therapeutic use of PAS and its salts].
NILSSON H
Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
[No Abstract] [Full Text] [Related]
3. [On PAS calcium salts].
SMOLAREK W
Tuberkulosearzt; 1953 May; 7(5):303-5. PubMed ID: 13090340
[No Abstract] [Full Text] [Related]
4. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
NIELSEN E; PRAETORIUS E
Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
[No Abstract] [Full Text] [Related]
5. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
CITRON KM; KUPER SW
Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
[No Abstract] [Full Text] [Related]
6. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
BANG HO; STRANDGAARD E
Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
[No Abstract] [Full Text] [Related]
7. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
KOELZER PP; WEHR KH; GIESEN J
Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
[No Abstract] [Full Text] [Related]
8. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
[No Abstract] [Full Text] [Related]
9. [PAS blood content after peroral intake of different calcium-PAS-granulates].
SANZ MC; MULLER A
Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
[No Abstract] [Full Text] [Related]
10. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
RIEBER CW; SALINE M; FRIEDMAN MM
Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
[No Abstract] [Full Text] [Related]
11. Continued studies in concentrations of para-amino-salicylic acid (PAS) in the blood.
FROSTAD S
Acta Tuberc Pneumol Scand; 1961; 41():68-82. PubMed ID: 13895556
[No Abstract] [Full Text] [Related]
12. [Retarding effect of butazolidine on the elimination of PAS].
CURCHOD B; CHENET C; VIELHAUER S
Schweiz Z Tuberk; 1954; 11(3):175-84. PubMed ID: 13205179
[No Abstract] [Full Text] [Related]
13. [Oral administration of PAS].
RENARD J; COULET M; RIMBAULT Y
Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
[No Abstract] [Full Text] [Related]
14. [Paper electrophoretic study of binding of PAS with blood proteins].
WIEDERMANN D; TOVAREK J
Lek List; 1954 Jun; 9(12):270-1. PubMed ID: 13213205
[No Abstract] [Full Text] [Related]
15. The blood level determinations of PAS and isoniazid with vanillin.
DEEB EN; VITAGLIANO GR
J Am Pharm Assoc Am Pharm Assoc; 1955 Mar; 44(3):182-5. PubMed ID: 14353748
[No Abstract] [Full Text] [Related]
16. Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese.
Hong L; Jiang W; Pan H; Jiang Y; Zeng S; Zheng W
Drug Metab Dispos; 2011 Oct; 39(10):1904-9. PubMed ID: 21768272
[TBL] [Abstract][Full Text] [Related]
17. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
Miroshnichenko II; Sokolova GB; Mokhireva LV
Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
[TBL] [Abstract][Full Text] [Related]
19. [Modifications of gastric function induced by PAS and its salts].
FORATTINI C; SELMI W
Arch Tisiol Mal Appar Respir; 1951 Nov; 6(11):939-47. PubMed ID: 14915785
[No Abstract] [Full Text] [Related]
20. Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiency.
Held H; Fried F
Chemotherapy; 1977; 23(6):405-15. PubMed ID: 923330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
